Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes

Source : https://bmcendocrdisord.biomedcentral.com/articles/10.1186/s12902-020-00676-4

Background Skin autofluorescence (SAF) is a non-invasive marker of tissue accumulation of advanced glycation endproducts (AGE). Recently, we demonstrated in the general population that elevated SAF levels predict the development of type 2 diabetes (T2D), cardiovascular disease (CVD) and mortality. We evaluated whether elevated SAF may predict the development of CVD and mortality in individuals with T2D.